Favourable response to antithymocyte globulin therapy in resistant acute graft-versus-host disease.
Tagliabue
A
A
Corti
P
P
Viganò
E
E
Bonanomi
S
S
Uderzo
C
C
D000293:Adolescent; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D018572:Disease-Free Survival; D005260:Female; D006086:Graft vs Host Disease / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000401:mortality / Q000628:therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000401:mortality / Q000628:therapy*
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents